華泰證券(06886.HK)擬出資6億元設合夥投資醫療健康行業
格隆匯1月29日丨華泰證券(06886.HK)公吿,於2021年1月29日,公司董事會審議通過了《關於公司全資子公司華泰紫金投資有限責任公司投資設立產業基金的議案》,批准華泰紫金(公司全資附屬公司,作為普通合夥人)與江蘇投管(作為普通合夥人)、南京產業基金(作為有限合夥人)及北聯創業投資(作為有限合夥人)成立合夥企業以創立基金,以醫療健康行業為主要投資方向,包括生物醫藥、醫療器械、醫療服務等領域。
根據合夥協議,華泰紫金擔任基金管理人,向合夥企業提供投資諮詢、投資管理和其他服務,合夥企業向華泰紫金支付基金管理費。所有合夥人向合夥企業繳付的總出資額為人民幣30億元,其中華泰紫金出資6億元。
集團致力發掘潛在投資機會,以為股東帶來收益及取得更佳回報。董事相信,成立合夥企業為集團達致其投資組合多元化及為集團帶來穩定收入的投資良機。國信集團是江蘇省屬大型國有企業,江蘇投管作為落實國信集團戰略性新興產業投資的重要載體,出資參與基金運作,在基金的重大事項決策方面能夠憑藉江蘇投管與華泰紫金各自的專業和經驗累積,優勢互補,把握投資風向,掌握投資節點,做出合理準確的投資判斷,保障基金穩健、高效地運行。董事相信,有關項目發展與公司於新興業務的投資策略佈局相輔相成。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.